Regeneron Pharmaceuticals, Inc. (REGN) Investment Research Dashboard
About Regeneron Pharmaceuticals, Inc. (REGN) stock analysis
Get live REGN stock price $695.18, comprehensive Regeneron Pharmaceuticals, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time REGN stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses. Its therapeutic portfolio includes EYLEA, ...
Company Information
- CEO
- Leonard S. Schleifer
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 15410
Contact Information
- Website
- https://www.regeneron.com
- Address
- 777 Old Saw Mill River Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 15.2)
✓ Lower volatility stock (Beta: 0.24) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Regeneron Pharmaceuticals, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Regeneron Pharmaceuticals, Inc.
- ⚠Investors should consider how Regeneron Pharmaceuticals, Inc. fits within their overall portfolio allocation
Market Cap
71.62B
P/E Ratio (TTM)
15.24
Beta
0.24
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare REGN with peer companies:
- Price
- $288.41+3.60% (1D)
- Market cap
- 38.51B
- Price
- $872.23-1.87% (1D)
- Market cap
- 54.24B
- Price
- $301.12+3.47% (1D)
- Market cap
- 79.66B
- Price
- $319.63+2.73% (1D)
- Market cap
- 62.19B
- Price
- $385.70+1.94% (1D)
- Market cap
- 83.65B
- Price
- $29.00+0.69% (1D)
- Market cap
- 17.80B
- Price
- $569.54+2.40% (1D)
- Market cap
- 44.93B
- Price
- $129.93+9.30% (1D)
- Market cap
- 25.96B
- Price
- $523.33-0.87% (1D)
- Market cap
- 22.21B
- Price
- $77.50+0.75% (1D)
- Market cap
- 32.49B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
73/100 ⭐⭐⭐⭐⭐
- Overall
- +0.6%
- NYSE
- +0.7%
- NASDAQ
- +0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +1.9% | +2.8% | +4.0% | 19.2 | 98/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.5% | -0.5% | +3.1% | 22.3 | 74/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.6% | +1.2% | +1.5% | 24.0 | 73/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.9% | +1.7% | +0.2% | 25.3 | 66/100⭐⭐⭐⭐ |
| Consumer Defensive | -0.0% | +2.0% | +0.9% | 29.8 | 63/100⭐⭐⭐⭐ |
| Real Estate | +0.4% | +0.9% | -1.6% | 29.5 | 50/100⭐⭐⭐ |
| Energy | -1.7% | -3.3% | -3.7% | 19.2 | 39/100⭐⭐ |
| Utilities | -1.1% | -0.0% | -4.5% | 26.8 | 35/100⭐⭐ |
| Industrials | +0.7% | +0.5% | -9.8% | 30.0 | 21/100⭐ |
| Technology | +0.9% | -1.3% | -6.9% | 40.9 | 18/100⭐ |
| Consumer Cyclical | +0.3% | -1.7% | -6.0% | 42.8 | 14/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.